Medication reference
Landiolol
Monograph awaiting updateThis monograph will be updated in the future.
No original site article was mapped to this record. The available historical structured fields and official-source links are retained.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- landiolol
Source ID
H51-26E6AC100ED2A6961BCCF45F - Generic name
- Landiolol
Source ID
H51-45475949D160A3A677AC0546 - Class
- Cardiovascular and vasoactive
Source ID
H51-B2C14C19D45279BCEF85541C - Subclass
- Ultra-short-acting beta-1 blocker
Source ID
H51-E3F2A4AD83263C4B990458AA - Primary uses
- Short-term reduction of ventricular rate in supraventricular tachycardia including atrial fibrillation/flutter in adults
Source ID
H51-82DA5401F7AA77CEA893AE92
- Short-term reduction of ventricular rate in supraventricular tachycardia including atrial fibrillation/flutter in adults
- Mechanism
- Selectively blocks beta-1 adrenergic receptors and reduces heart rate, AV conduction, and contractility.
Source ID
H51-E3E5BA6CD5D1C1294779A97F - Mechanism level
- drug_specific
Source ID
H51-E2C55CBCF5BEEC328F97E12F - Basic dosing orientation
- Adult infusion | Existing preparation record; use current package insert for indication-specific selection | One 280 mg vial | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Existing continuous-infusion record | Dose per current label and hemodynamic status | Continuous infusion; titration-specific | Clinical-response dependent | Continuous IV infusion
Source ID
H51-B67F357ECEEBD19BC7C05C25 - Administration orientation
- Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93; Titrate to ventricular-rate target; 280 mg/50 mL (5.6 mg/mL); Dose per current label and hemodynamic status; Titrate to ventricular-rate target
Source ID
H51-FD0ED9F6F2283DA7946596C9 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-A2967BAC6408EF440E0A6E3D - Key safety orientation
- Severe bradycardia, heart block, hypotension, cardiogenic shock, and decompensated heart failure.
Source ID
H51-867F27EECFAF82BF12F31553 - Continuous ECG and blood-pressure monitoring are required.
Source ID
H51-D3C5E76E6E4EFFA13C91CF2B
- Severe bradycardia, heart block, hypotension, cardiogenic shock, and decompensated heart failure.
- Coverage path
- structured_local_snapshot
Source ID
H51-D224AC62DEC6DE5FD33ECDF1 - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-0EE481ED4252D883AC88F24F - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27e7f20f-78a4-f1a9-e063-6394a90ae465 (opens in a new tab)
Source ID
H51-4B541B7B69C799D2CA946F73 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-B2E6797BFCEB1C05EB6502DB - Search text
- Landiolol Cardiovascular and vasoactive Ultra-short-acting beta-1 blocker Short-term reduction of ventricular rate in supraventricular tachycardia including atrial fibrillation/flutter in adults Selectively blocks beta-1 adrenergic receptors and reduces heart rate, AV conduction, and contractility. Adult infusion | Existing preparation record; use current package insert for indication-specific selection | One 280 mg vial | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Existing continuous-infusion record | Dose per current label and hemodynamic status | Continuous infusion; titration-specific | Clinical-response dependent | Continuous IV infusion Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93; Titrate to ventricular-rate target; 280 mg/50 mL (5.6 mg/mL); Dose per current label and hemodynamic status; Titrate to ventricular-rate target Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Severe bradycardia, heart block, hypotension, cardiogenic shock, and decompensated heart failure. Continuous ECG and blood-pressure monitoring are required. Structured GlobalRPh route snapshot
Source ID
H51-EC652A9DC0D26BF3FD7FD036 - Official access mode
- direct_label
Source ID
H51-A03032387AFBCF73A9A3F211 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27e7f20f-78a4-f1a9-e063-6394a90ae465 (opens in a new tab)
Source ID
H51-48DFD1AE65CB91A2ABBBD178 - Official access reason
- A source-specific DailyMed label route is available.
Source ID
H51-AF25259793A6E0C4DDE946FB - Label snapshot available
- true
Source ID
H51-B77CD7DB3F2AC769E5B27A80 - Label snapshot setid
- 27e7f20f-78a4-f1a9-e063-6394a90ae465
Source ID
H51-1A610B7C1D7643222D194A8A
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- A retrieved source document is available; clinical reconciliation and a second-source claim map remain incomplete
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- current_label_review_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Source kind
- label_snapshot
- Local pointer
- /mechanism_summary
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
No separate structured rows were bundled for IV push, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-01E6B5647B1448C7832E36A1Source IDH51-277E4465D49851A210E7EC48 | One 280 mg vialSource IDH51-DE96D1A9F60358237134C5D1 | Reconstitute with 50 mL NS or D5W and gently swirl.Source IDH51-9AE26B1E3E80C40B6E64CE74 | NS or D5W used for reconstitutionSource IDH51-4CC914441761417E4DCFB365 | 50 mLSource IDH51-F4AD8E2DDE008F77A8CE5EAC | 5.6 mg/mLSource IDH51-3190CBA7240E4D5F14B4AD6E | Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93Source IDH51-CCF6AE4C4C9DFF808B2D8A90 | NS preparation: use within 4 hours at room temperature. D5W preparation: use within 48 hours at room temperature.Source IDH51-D14E613BDE21B14A5F95A7AD | Use immediately when possible and discard unused portion.Source IDH51-E759348E6BBF0B644F6BA473 |
Historical DailyMed label snapshot
Recovered v5.1 source content; historical, awaiting current review.
- Id
- landiolol
Source ID
H51-F42AD5ED7F34CD0FE9270538 - Catalog name
- Landiolol
Source ID
H51-AD4BEDAD6DC1C520131B2887 - Selection status
- accepted_high_confidence
Source ID
H51-9BA4A38C30438C20E56D09D9 - Confidence
- very_high
Source ID
H51-84FE1E9BD88AFD5D184C3299 - Match path
- verified_direct_label
Source ID
H51-D1948C6693F10AA85B7491DE - Brand name
- RAPIBLYK
Source ID
H51-38F67450FC222A4C5724423A - Label title
- RAPIBLYK (landiolol) injection, powder, lyophilized, for solution
Source ID
H51-EADCE55FC7B5F25A3C5BC511 - Setid
- 27e7f20f-78a4-f1a9-e063-6394a90ae465
Source ID
H51-7FB482BF1AB249EA4872CBD8 - Route
- Titrated continuous intravenous infusion
Source ID
H51-22FBC480435DC903759C4953 - Dosage form
- Lyophilized powder for reconstitution
Source ID
H51-8FC47FA3A369CE310A177EAF - Dosage administration summary
- Administer as a continuous intravenous infusion in a monitored setting and titrate to ventricular-rate response.
Source ID
H51-3C763D0DB6F673CCF9C7941C - With normal cardiac function, the current label starts at 9 mcg/kg/min and permits 9 mcg/kg/min increases at 10-minute intervals to 36 mcg/kg/min. With impaired cardiac function, use the lower 1 mcg/kg/min starting and titration steps.
Source ID
H51-C8E94E640AFAA099E187DE11 - Reconstitute the 280 mg vial with 50 mL of 0.9% sodium chloride or 5% dextrose to 5.6 mg/mL and follow the diluent-specific in-use limits.
Source ID
H51-B7C8FD77CEBA18CB972BAE90
- Administer as a continuous intravenous infusion in a monitored setting and titrate to ventricular-rate response.
- Dosage forms strengths
- 280 mg landiolol, equivalent to 300 mg landiolol hydrochloride, in a single-dose vial
Source ID
H51-89AD32F1109DFAA458E30E24
- 280 mg landiolol, equivalent to 300 mg landiolol hydrochloride, in a single-dose vial
- Mechanism summary
- Landiolol is an ultra-short-acting, beta1-selective adrenergic-receptor blocker that reduces heart rate and atrioventricular conduction.
Source ID
H51-3D05A5E03DF2CC05BCDE5677 - Scope note
- Selected RAPIBLYK label. Continuous rhythm, heart-rate, blood-pressure, and heart-failure monitoring are required.
Source ID
H51-BE497617F7DCEF621F52C8A6 - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27e7f20f-78a4-f1a9-e063-6394a90ae465 (opens in a new tab)
Source ID
H51-F5FA172B5FB25EE9DA26B357 - Reviewed on
- 2026-08-31
Source ID
H51-890F4F074364225AEC8948B6 - Mechanism source
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
Source ID
H51-4470C29623EF06D32A1827C6 - Source sections
- Dosage and Administration
Source ID
H51-FE7E9CA7961C0EEC43FFE6B6 - Dosage Forms and Strengths
Source ID
H51-2AEB7D9539DD8B0DD0884A4C - Clinical Pharmacology or Microbiology as applicable
Source ID
H51-1FA6A27316AE9B779E9553C9
- Dosage and Administration
- Retrieval method
- Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
Source ID
H51-DFD5CE3F58DC7EC1A439A776 - Label status
- current
Source ID
H51-41C606FB0C9686EBB6C1F658 - Disclaimer
- Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
Source ID
H51-BAFBBAEEFC76D8E387A1F08A
Historical continuous-infusion guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Standard concentration | Initial rate | Titration | Maximum | Notes |
|---|---|---|---|---|---|
Source IDH51-2001D46D54937DB624F01FE5Source IDH51-4673DF0D4131E34B20372D36 | 280 mg/50 mL (5.6 mg/mL)Source IDH51-A0F535BD92C5EED652EB0225 | Dose per current label and hemodynamic statusSource IDH51-21E4F3D9B6487B529FCB11E1 | Titrate to ventricular-rate targetSource IDH51-D22DF6E6D05E36D3905DDFF9 | Current label maximumSource IDH51-6712119276ECF7C9EBE25E8F | Transition to oral beta blocker using the label-directed overlap and taper method.Source IDH51-B55C3020E3B88A5FE1336FC2 |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-628F428EBC6D2724CC468810Source IDH51-DC9B7ACDD235A1397653ECC8 | Adult infusionSource IDH51-863AD2B4D77F7653B1BD81D2 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-A82016A094542C59B5C21B0D | One 280 mg vialSource IDH51-497E64AD92F203EB98675F11 | Not normalized in the preparation recordSource IDH51-03411431FADB35BB0203EA4D | See current package insert and professional guidanceSource IDH51-F7ED00E1397EE1F9F0DDF016 | Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93Source IDH51-7A6ECC44FAD436FC0D69BDFF | Existing GlobalRPh structured preparation snapshotSource IDH51-1E8A8475C5C4F768347C9908 | Use immediately when possible and discard unused portion.Source IDH51-08BDDA0E576D08A61CE5285C |
Source IDH51-55F4EBF0D3E6025DA6D41852Source IDH51-95DA27C07A2C7F31085D66B9 | AdultSource IDH51-3A3A93620465B76ADFC93777 | Existing continuous-infusion recordSource IDH51-A75BC2E41494AE66DB21355A | Dose per current label and hemodynamic statusSource IDH51-F772363F12A5A46B2C4F15EC | Continuous infusion; titration-specificSource IDH51-DCBBB023B6C9541EBCFFE65D | Clinical-response dependentSource IDH51-642FBEAD772C25E3AF340117 | Titrate to ventricular-rate targetSource IDH51-A15B6579A5D70673DFA45368 | Existing GlobalRPh continuous-infusion snapshotSource IDH51-4C9A977113C8E10BA028A3F8 | Current label maximum Transition to oral beta blocker using the label-directed overlap and taper method.Source IDH51-517234BE783343F50E74A1DB |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- current_label_review_required
Source ID
H51-F1A260D4049AE78A5E853369 - Summary
- Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-D08E0656853B6786A11F6C58 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-E1A516B91DF2ED25C9293BD2
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Short-term reduction of ventricular rate in supraventricular tachycardia including atrial fibrillation/flutter in adults
Source ID
H51-120524BBFAB46277F9A0F9F4
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Severe bradycardia, heart block, hypotension, cardiogenic shock, and decompensated heart failure.
Source ID
H51-D1F116741CCDF1A3B719F635 - Continuous ECG and blood-pressure monitoring are required.
Source ID
H51-756549D12EB4E62556D2B9A1
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
- Continuous ECG
Source ID
H51-98DC7836E07B4D494399367A - Blood pressure
Source ID
H51-49DF8363E08D864D84C6D1C5 - Signs of heart failure and bronchospasm
Source ID
H51-92EBE4E7DC6EA789D27B275A
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
landiololSource ID
H51-9C7071B30663C08A787799E2Generic name
LandiololSource ID
H51-D373976861897BE2EA89A720Brand names
- Rapiblyk
Source ID
H51-5F83A42F2B3CF887AE87191C
Class
Cardiovascular and vasoactiveSource ID
H51-BBB1533D282F287D8A48AFB3Subclass
Ultra-short-acting beta-1 blockerSource ID
H51-559AE7F53BC67DDE92E0EA86Summary
Ultra-short-acting beta-1 blocker supplied as a 280 mg lyophilized vial and prepared at 5.6 mg/mL for continuous infusion.Source ID
H51-4D01A4C9D6114A39BD5E480CPopulations
- Adult
Source ID
H51-2ED22F557A97EBD3F16E188E
Evidence tier
Current-label candidate - verify exact productSource ID
H51-6C83BE2ED5D664AC7485CF60High alert
falseSource ID
H51-EFA41EA394DDD8B51C581FD3Hazardous
falseSource ID
H51-5706B176A448DDF0A69423C4Status
ActiveSource ID
H51-03CBB4484E33A285BB1286B4Reviewed
2026-08-29Source ID
H51-3E09D08515FFA8B4895B7BE8Version added
1.2Source ID
H51-8066390A2FB20FC3D7524C6ESources
| Label | Url | Kind |
|---|---|---|
Source IDH51-DC407EE46185487DC7E4CF32Source IDH51-C152B0CF9D5A6EE94AD9CC61 | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27e7f20f-78a4-f1a9-e063-6394a90ae465 (opens in a new tab)Source IDH51-DF261130101A188C7CFFF3E7 | PrimarySource IDH51-B76E79980F8AC69F063B864B |
Source IDH51-A86CEC62766676E58DD7DA6DSource IDH51-83F119AC7919983879500C88 | legacy:autoSource IDH51-D32B255AEF37E97F46DE42BB | LegacySource IDH51-FDDFD39D02337BE999AC94FC |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-261F3BB14177DD3583AC7900 - Audited on
- 2026-08-30
Source ID
H51-4C8D2B6DB445A320ED61653C - Level
- amber
Source ID
H51-791332A5B03DAE7BA6C8D85A - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-E12665AFACCA01B699FE5AA7 - Exact current label candidate
- false
Source ID
H51-B2D00B3861956F8BB0423A3D - Selected setid
- 27e7f20f-78a4-f1a9-e063-6394a90ae465
Source ID
H51-03FCEEE209B770A9D33AD821 - Numeric support ratio
- 0
Source ID
H51-DA5D16870E3D3EE961CEC09D - Reference url count
- 1
Source ID
H51-560A7D6A06813129DF42F634 - Broken reference count
- 0
Source ID
H51-FB1AA9AE93B9B2BE79872983 - Point of use confirmation required
- true
Source ID
H51-95B96B6214DE7FD8F0B58E1E - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-ADE106CAA3B71DE69A115232 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Landiolol (opens in a new tab)
Source ID
H51-5DCF5FCF8DF9A9FBFAB3A936
Dosing source fields
Id
landiololSource ID
H51-76369F3CA4F5F868DE961ACEGeneric name
LandiololSource ID
H51-F84A87C9E73D94837E8BFE95Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-66C769FBF2C9EC5847273F8CPackage insert
- Query name
- Landiolol
Source ID
H51-79AA5F65CF6E41D771079FF9 - Preferred setid
- 27e7f20f-78a4-f1a9-e063-6394a90ae465
Source ID
H51-11F0E17DF91A3182C8D8A16E - Product and route must match
- true
Source ID
H51-EDACB9E1177061E341709FCC - Live current label enabled
- false
Source ID
H51-B1992515BC4098A46D9AB3C2 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-3E0688731FBE838D5CDA4DFA - Direct official label access enabled
- true
Source ID
H51-3AE1A262F709E627CF5F3F1E - Outbound server request required
- false
Source ID
H51-87B81928FB4562358529E88B - Local summary status
- not_bundled
Source ID
H51-7BB58A17E42C993DAF8EF18B
Clinical review
- Locally normalized
- false
Source ID
H51-9A926535811BEB8C377A06FF - Reviewed
- 2026-08-29
Source ID
H51-913D431D736D8BDF084E911A - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-4F42E4891E3C1FE5CEBE4C17
Clinical release verification
- Audit version
- 3.4
Source ID
H51-DA808AD3F2774F93BBCB1158 - Audited on
- 2026-08-30
Source ID
H51-D0A349D22030F41BEE623B07 - Level
- amber
Source ID
H51-E41630322B435092FB2CF260 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-7A096CD1E1A0B0A2F775C3FC - Exact current label candidate
- false
Source ID
H51-A434CB6D9F44327FFBF3C54A - Selected setid
- 27e7f20f-78a4-f1a9-e063-6394a90ae465
Source ID
H51-3878BFE4E31D6DD7B216BCEF - Numeric support ratio
- 0
Source ID
H51-4433D83D0C6B904D0CD7945F - Reference url count
- 1
Source ID
H51-DED4036BD00D67B7E08B1519 - Broken reference count
- 0
Source ID
H51-EC0867137471AF75B580A3C5 - Point of use confirmation required
- true
Source ID
H51-FFE40DA7ACCEF29A933FCA75 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-7BEF4670A5BA751416B62179 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Landiolol (opens in a new tab)
Source ID
H51-F3AFC818F4CBCAFCEC9DC965
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- landiolol
Source ID
H51-BCA92F09C915AB9D3630D9B0 - Name
- Landiolol
Source ID
H51-192DC07FE3906E1C14374578 - Brands
- Rapiblyk
Source ID
H51-6703F109D7376B6DB42F805C - Therapeutic class
- Cardiovascular and vasoactive
Source ID
H51-0D934D7E2AA5467F3EEB41A5 - Review version
- 3.1
Source ID
H51-B64622538EB3B563ADF00582 - Review date
- 2026-08-30
Source ID
H51-02DA0C304B4E1B9DB67BFE53 - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-3AEFFD95A13DD9436970D8D1 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-D62E299FD99A797C30672E3D - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-04DF267985B15CE68962A131
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-1068DF5B4348CADC6B69C01D - Reconstitution concentration
- Reconstitute with 50 mL NS or D5W and gently swirl.
Source ID
H51-33399054EC4543C783024B20 - Maximum or recommended final concentration
- 280 mg/50 mL (5.6 mg/mL)
Source ID
H51-CEF6F90AA8A2A3C55DC14C33 - Appropriate standardized containers
- 50 mL
Source ID
H51-53FBCDD0DEFFE4417C34D244 - Adult dosing range
- One 280 mg vial Dose per current label and hemodynamic status
Source ID
H51-98A424C8D3F4B2DB2901B82C - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-51EB610E4325194ABBC9984E - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-02B342AF584844F26B8042B8 - Infusion time
- Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93 Dose per current label and hemodynamic status
Source ID
H51-46E0169269B555E4D76F2D07 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6D01025B76B84E31A1A2A6BE - Current manufacturer labeling
- Setid
- 27e7f20f-78a4-f1a9-e063-6394a90ae465
Source ID
H51-5F5727DA1498FDB0C00C2311 - Match confidence
- unresolved
Source ID
H51-BBF130FADE3305570512A0E3 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Landiolol (opens in a new tab)
Source ID
H51-156B476CE3A772B7424DD1A7
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-9A09CA7B23FF9260A680DC17
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-DE12C105DF1021A855A2D2FC
- Maximum or recommended final concentration
- Primary
- existing_structured_record
Source ID
H51-D40CD1EB72A2760F3FFFA3B4
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-D5D7D3F73F40320CE64690D6
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-AD5E30E35193FC3B9BDA517B
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-18FDE8895009589CB1E78021
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-E5305CA7A105772BFD686C4B
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-50EBD0CC6AF279C862C70E53
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-6DCEA7FD1303D8C2B037C3A9
- Current manufacturer labeling
- Primary
- DailyMed current-label gateway
Source ID
H51-A093CEE43C023B27685E40AC
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-FEED401D04F749FFF126F307 - Guide generation allowed
- true
Source ID
H51-9E1D8EA051744A02D2C17C20
- Pediatric
- Applicability
- not_established
Source ID
H51-6596683324DFAE11678CD41F - Guide generation allowed
- false
Source ID
H51-6C6FDB761E7E5D6C782D6F0B
- Neonatal
- Applicability
- not_established
Source ID
H51-F2E06C99FE9E9B11993CA919 - Guide generation allowed
- false
Source ID
H51-47B35A298120B9618EBD791A
- Route presence
- Structured dilution
- true
Source ID
H51-A8E82FB3AC12638F172829DA - Iv push
- false
Source ID
H51-5E380301450D86A1E414BFC2 - Continuous infusion
- true
Source ID
H51-9715DDA077012B9A6F087D2D - Pediatric source
- false
Source ID
H51-B7F1B8499812B41A9D6B8221 - Neonatal source
- false
Source ID
H51-294118602529701A8A1E7F9B
- Legacy reference
- Status
- not_available
Source ID
H51-0BF915FF33D5C7C72B6E9082
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-882936034BBE320BBAEBBBA1 - Existing setids
- 27e7f20f-78a4-f1a9-e063-6394a90ae465
Source ID
H51-94C078ECD8B054E78F80F558
- 27e7f20f-78a4-f1a9-e063-6394a90ae465
- Concentration values detected
High Unit Text 5.6Source ID
H51-7724139FDA90BBE662356A94Source ID
H51-4AC9C6B9D01D60B92ACEEB68mg Source ID
H51-E513254F3EFB8999B17F95A85.6 mg/mL Source ID
H51-60508C0EBF44AB06EEEBEE3C- Source files
- catalog.json
Source ID
H51-4B05123F41A0E2A1FAED3EE1 - dosing.json
Source ID
H51-58A0A1364EC9425C320A2CDE - new-in-v1.2.json
Source ID
H51-BB24117F01AB73A38981CCE4
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-B558E50D9F565EBE80806400
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-9C7071B30663C08A787799E2 | catalog.json/records/144/id | Historical; current review incomplete |
H51-D373976861897BE2EA89A720 | catalog.json/records/144/generic_name | Historical; current review incomplete |
H51-5F83A42F2B3CF887AE87191C | catalog.json/records/144/brand_names/0 | Historical; current review incomplete |
H51-BBB1533D282F287D8A48AFB3 | catalog.json/records/144/class | Historical; current review incomplete |
H51-559AE7F53BC67DDE92E0EA86 | catalog.json/records/144/subclass | Historical; current review incomplete |
H51-4D01A4C9D6114A39BD5E480C | catalog.json/records/144/summary | Historical; current review incomplete |
H51-120524BBFAB46277F9A0F9F4 | catalog.json/records/144/common_uses/0 | Historical; current review incomplete |
H51-01E6B5647B1448C7832E36A1 | catalog.json/records/144/preparations/0 | Historical; current review incomplete |
H51-277E4465D49851A210E7EC48 | catalog.json/records/144/preparations/0/population | Historical; current review incomplete |
H51-DE96D1A9F60358237134C5D1 | catalog.json/records/144/preparations/0/amount | Historical; current review incomplete |
H51-9AE26B1E3E80C40B6E64CE74 | catalog.json/records/144/preparations/0/reconstitution | Historical; current review incomplete |
H51-4CC914441761417E4DCFB365 | catalog.json/records/144/preparations/0/diluent | Historical; current review incomplete |
H51-F4AD8E2DDE008F77A8CE5EAC | catalog.json/records/144/preparations/0/final_volume | Historical; current review incomplete |
H51-3190CBA7240E4D5F14B4AD6E | catalog.json/records/144/preparations/0/concentration | Historical; current review incomplete |
H51-CCF6AE4C4C9DFF808B2D8A90 | catalog.json/records/144/preparations/0/rate | Historical; current review incomplete |
H51-D14E613BDE21B14A5F95A7AD | catalog.json/records/144/preparations/0/stability | Historical; current review incomplete |
H51-E759348E6BBF0B644F6BA473 | catalog.json/records/144/preparations/0/notes | Historical; current review incomplete |
H51-2001D46D54937DB624F01FE5 | catalog.json/records/144/continuous_infusions/0 | Historical; current review incomplete |
H51-4673DF0D4131E34B20372D36 | catalog.json/records/144/continuous_infusions/0/population | Historical; current review incomplete |
H51-A0F535BD92C5EED652EB0225 | catalog.json/records/144/continuous_infusions/0/standard_concentration | Historical; current review incomplete |
H51-21E4F3D9B6487B529FCB11E1 | catalog.json/records/144/continuous_infusions/0/initial_rate | Historical; current review incomplete |
H51-D22DF6E6D05E36D3905DDFF9 | catalog.json/records/144/continuous_infusions/0/titration | Historical; current review incomplete |
H51-6712119276ECF7C9EBE25E8F | catalog.json/records/144/continuous_infusions/0/maximum | Historical; current review incomplete |
H51-B55C3020E3B88A5FE1336FC2 | catalog.json/records/144/continuous_infusions/0/notes | Historical; current review incomplete |
H51-D1F116741CCDF1A3B719F635 | catalog.json/records/144/warnings/0 | Historical; current review incomplete |
H51-756549D12EB4E62556D2B9A1 | catalog.json/records/144/warnings/1 | Historical; current review incomplete |
H51-98DC7836E07B4D494399367A | catalog.json/records/144/monitoring/0 | Historical; current review incomplete |
H51-49DF8363E08D864D84C6D1C5 | catalog.json/records/144/monitoring/1 | Historical; current review incomplete |
H51-92EBE4E7DC6EA789D27B275A | catalog.json/records/144/monitoring/2 | Historical; current review incomplete |
H51-2ED22F557A97EBD3F16E188E | catalog.json/records/144/populations/0 | Historical; current review incomplete |
H51-6C83BE2ED5D664AC7485CF60 | catalog.json/records/144/evidence_tier | Historical; current review incomplete |
H51-EFA41EA394DDD8B51C581FD3 | catalog.json/records/144/high_alert | Historical; current review incomplete |
H51-5706B176A448DDF0A69423C4 | catalog.json/records/144/hazardous | Historical; current review incomplete |
H51-03CBB4484E33A285BB1286B4 | catalog.json/records/144/status | Historical; current review incomplete |
H51-3E09D08515FFA8B4895B7BE8 | catalog.json/records/144/reviewed | Historical; current review incomplete |
H51-8066390A2FB20FC3D7524C6E | catalog.json/records/144/version_added | Historical; current review incomplete |
H51-DC407EE46185487DC7E4CF32 | catalog.json/records/144/sources/0 | Historical; current review incomplete |
H51-C152B0CF9D5A6EE94AD9CC61 | catalog.json/records/144/sources/0/label | Historical; current review incomplete |
H51-DF261130101A188C7CFFF3E7 | catalog.json/records/144/sources/0/url | Historical; current review incomplete |
H51-B76E79980F8AC69F063B864B | catalog.json/records/144/sources/0/kind | Historical; current review incomplete |
H51-A86CEC62766676E58DD7DA6D | catalog.json/records/144/sources/1 | Historical; current review incomplete |
H51-83F119AC7919983879500C88 | catalog.json/records/144/sources/1/label | Historical; current review incomplete |
H51-D32B255AEF37E97F46DE42BB | catalog.json/records/144/sources/1/url | Historical; current review incomplete |
H51-FDDFD39D02337BE999AC94FC | catalog.json/records/144/sources/1/kind | Historical; current review incomplete |
H51-F0B843D035FF78A79C04298E | catalog.json/records/144/legacy_title | Historical; current review incomplete |
H51-261F3BB14177DD3583AC7900 | catalog.json/records/144/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-4C8D2B6DB445A320ED61653C | catalog.json/records/144/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-791332A5B03DAE7BA6C8D85A | catalog.json/records/144/clinical_release_verification/level | Historical; current review incomplete |
H51-E12665AFACCA01B699FE5AA7 | catalog.json/records/144/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-B2D00B3861956F8BB0423A3D | catalog.json/records/144/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-03FCEEE209B770A9D33AD821 | catalog.json/records/144/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-67F67401F60F45AD10108BE7 | catalog.json/records/144/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-DA5D16870E3D3EE961CEC09D | catalog.json/records/144/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-560A7D6A06813129DF42F634 | catalog.json/records/144/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-FB1AA9AE93B9B2BE79872983 | catalog.json/records/144/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-95B96B6214DE7FD8F0B58E1E | catalog.json/records/144/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-ADE106CAA3B71DE69A115232 | catalog.json/records/144/clinical_release_verification/note | Historical; current review incomplete |
H51-5DCF5FCF8DF9A9FBFAB3A936 | catalog.json/records/144/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-F42AD5ED7F34CD0FE9270538 | dailymed-label-snapshots-v5.1.json/records/36/id | Historical; current review incomplete |
H51-AD4BEDAD6DC1C520131B2887 | dailymed-label-snapshots-v5.1.json/records/36/catalog_name | Historical; current review incomplete |
H51-9BA4A38C30438C20E56D09D9 | dailymed-label-snapshots-v5.1.json/records/36/selection_status | Historical; current review incomplete |
H51-84FE1E9BD88AFD5D184C3299 | dailymed-label-snapshots-v5.1.json/records/36/confidence | Historical; current review incomplete |
H51-D1948C6693F10AA85B7491DE | dailymed-label-snapshots-v5.1.json/records/36/match_path | Historical; current review incomplete |
H51-38F67450FC222A4C5724423A | dailymed-label-snapshots-v5.1.json/records/36/brand_name | Historical; current review incomplete |
H51-EADCE55FC7B5F25A3C5BC511 | dailymed-label-snapshots-v5.1.json/records/36/label_title | Historical; current review incomplete |
H51-7FB482BF1AB249EA4872CBD8 | dailymed-label-snapshots-v5.1.json/records/36/setid | Historical; current review incomplete |
H51-22FBC480435DC903759C4953 | dailymed-label-snapshots-v5.1.json/records/36/route | Historical; current review incomplete |
H51-8FC47FA3A369CE310A177EAF | dailymed-label-snapshots-v5.1.json/records/36/dosage_form | Historical; current review incomplete |
H51-3C763D0DB6F673CCF9C7941C | dailymed-label-snapshots-v5.1.json/records/36/dosage_administration_summary/0 | Historical; current review incomplete |
H51-C8E94E640AFAA099E187DE11 | dailymed-label-snapshots-v5.1.json/records/36/dosage_administration_summary/1 | Historical; current review incomplete |
H51-B7C8FD77CEBA18CB972BAE90 | dailymed-label-snapshots-v5.1.json/records/36/dosage_administration_summary/2 | Historical; current review incomplete |
H51-89AD32F1109DFAA458E30E24 | dailymed-label-snapshots-v5.1.json/records/36/dosage_forms_strengths/0 | Historical; current review incomplete |
H51-3D05A5E03DF2CC05BCDE5677 | dailymed-label-snapshots-v5.1.json/records/36/mechanism_summary | Historical; current review incomplete |
H51-BE497617F7DCEF621F52C8A6 | dailymed-label-snapshots-v5.1.json/records/36/scope_note | Historical; current review incomplete |
H51-360CA3083EE527D23AC0C0EC | dailymed-label-snapshots-v5.1.json/records/36/labeler | Historical; current review incomplete |
H51-F5FA172B5FB25EE9DA26B357 | dailymed-label-snapshots-v5.1.json/records/36/official_label_url | Historical; current review incomplete |
H51-890F4F074364225AEC8948B6 | dailymed-label-snapshots-v5.1.json/records/36/reviewed_on | Historical; current review incomplete |
H51-4470C29623EF06D32A1827C6 | dailymed-label-snapshots-v5.1.json/records/36/mechanism_source | Historical; current review incomplete |
H51-FE7E9CA7961C0EEC43FFE6B6 | dailymed-label-snapshots-v5.1.json/records/36/source_sections/0 | Historical; current review incomplete |
H51-2AEB7D9539DD8B0DD0884A4C | dailymed-label-snapshots-v5.1.json/records/36/source_sections/1 | Historical; current review incomplete |
H51-1FA6A27316AE9B779E9553C9 | dailymed-label-snapshots-v5.1.json/records/36/source_sections/2 | Historical; current review incomplete |
H51-DFD5CE3F58DC7EC1A439A776 | dailymed-label-snapshots-v5.1.json/records/36/retrieval_method | Historical; current review incomplete |
H51-41C606FB0C9686EBB6C1F658 | dailymed-label-snapshots-v5.1.json/records/36/label_status | Historical; current review incomplete |
H51-BAFBBAEEFC76D8E387A1F08A | dailymed-label-snapshots-v5.1.json/records/36/disclaimer | Historical; current review incomplete |
H51-76369F3CA4F5F868DE961ACE | dosing.json/records/144/id | Historical; current review incomplete |
H51-F84A87C9E73D94837E8BFE95 | dosing.json/records/144/generic_name | Historical; current review incomplete |
H51-66C769FBF2C9EC5847273F8C | dosing.json/records/144/coverage_status | Historical; current review incomplete |
H51-79AA5F65CF6E41D771079FF9 | dosing.json/records/144/package_insert/query_name | Historical; current review incomplete |
H51-11F0E17DF91A3182C8D8A16E | dosing.json/records/144/package_insert/preferred_setid | Historical; current review incomplete |
H51-EDACB9E1177061E341709FCC | dosing.json/records/144/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-B1992515BC4098A46D9AB3C2 | dosing.json/records/144/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-3E0688731FBE838D5CDA4DFA | dosing.json/records/144/package_insert/source_priority | Historical; current review incomplete |
H51-3AE1A262F709E627CF5F3F1E | dosing.json/records/144/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-87B81928FB4562358529E88B | dosing.json/records/144/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-7BB58A17E42C993DAF8EF18B | dosing.json/records/144/package_insert/local_summary_status | Historical; current review incomplete |
H51-F1A260D4049AE78A5E853369 | dosing.json/records/144/renal/classification | Historical; current review incomplete |
H51-D08E0656853B6786A11F6C58 | dosing.json/records/144/renal/summary | Historical; current review incomplete |
H51-E1A516B91DF2ED25C9293BD2 | dosing.json/records/144/renal/method_note | Historical; current review incomplete |
H51-628F428EBC6D2724CC468810 | dosing.json/records/144/existing_route_snapshots/0 | Historical; current review incomplete |
H51-DC9B7ACDD235A1397653ECC8 | dosing.json/records/144/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-863AD2B4D77F7653B1BD81D2 | dosing.json/records/144/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-A82016A094542C59B5C21B0D | dosing.json/records/144/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-497E64AD92F203EB98675F11 | dosing.json/records/144/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-03411431FADB35BB0203EA4D | dosing.json/records/144/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-F7ED00E1397EE1F9F0DDF016 | dosing.json/records/144/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-7A6ECC44FAD436FC0D69BDFF | dosing.json/records/144/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-1E8A8475C5C4F768347C9908 | dosing.json/records/144/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-08BDDA0E576D08A61CE5285C | dosing.json/records/144/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-55F4EBF0D3E6025DA6D41852 | dosing.json/records/144/existing_route_snapshots/1 | Historical; current review incomplete |
H51-95DA27C07A2C7F31085D66B9 | dosing.json/records/144/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-3A3A93620465B76ADFC93777 | dosing.json/records/144/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-A75BC2E41494AE66DB21355A | dosing.json/records/144/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-F772363F12A5A46B2C4F15EC | dosing.json/records/144/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-DCBBB023B6C9541EBCFFE65D | dosing.json/records/144/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-642FBEAD772C25E3AF340117 | dosing.json/records/144/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-A15B6579A5D70673DFA45368 | dosing.json/records/144/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-4C9A977113C8E10BA028A3F8 | dosing.json/records/144/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-517234BE783343F50E74A1DB | dosing.json/records/144/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-9A926535811BEB8C377A06FF | dosing.json/records/144/clinical_review/locally_normalized | Historical; current review incomplete |
H51-913D431D736D8BDF084E911A | dosing.json/records/144/clinical_review/reviewed | Historical; current review incomplete |
H51-4F42E4891E3C1FE5CEBE4C17 | dosing.json/records/144/clinical_review/status | Historical; current review incomplete |
H51-DA808AD3F2774F93BBCB1158 | dosing.json/records/144/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-D0A349D22030F41BEE623B07 | dosing.json/records/144/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-E41630322B435092FB2CF260 | dosing.json/records/144/clinical_release_verification/level | Historical; current review incomplete |
H51-7A096CD1E1A0B0A2F775C3FC | dosing.json/records/144/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-A434CB6D9F44327FFBF3C54A | dosing.json/records/144/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-3878BFE4E31D6DD7B216BCEF | dosing.json/records/144/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-EF7CDDFEC78263D35621B134 | dosing.json/records/144/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-4433D83D0C6B904D0CD7945F | dosing.json/records/144/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-DED4036BD00D67B7E08B1519 | dosing.json/records/144/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-EC0867137471AF75B580A3C5 | dosing.json/records/144/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-FFE40DA7ACCEF29A933FCA75 | dosing.json/records/144/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-7BEF4670A5BA751416B62179 | dosing.json/records/144/clinical_release_verification/note | Historical; current review incomplete |
H51-F3AFC818F4CBCAFCEC9DC965 | dosing.json/records/144/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-26E6AC100ED2A6961BCCF45F | first-look-v5.1.json/records/144/id | Historical; current review incomplete |
H51-45475949D160A3A677AC0546 | first-look-v5.1.json/records/144/generic_name | Historical; current review incomplete |
H51-B2C14C19D45279BCEF85541C | first-look-v5.1.json/records/144/class | Historical; current review incomplete |
H51-E3F2A4AD83263C4B990458AA | first-look-v5.1.json/records/144/subclass | Historical; current review incomplete |
H51-82DA5401F7AA77CEA893AE92 | first-look-v5.1.json/records/144/primary_uses/0 | Historical; current review incomplete |
H51-E3E5BA6CD5D1C1294779A97F | first-look-v5.1.json/records/144/mechanism | Historical; current review incomplete |
H51-E2C55CBCF5BEEC328F97E12F | first-look-v5.1.json/records/144/mechanism_level | Historical; current review incomplete |
H51-B67F357ECEEBD19BC7C05C25 | first-look-v5.1.json/records/144/basic_dosing_orientation | Historical; current review incomplete |
H51-FD0ED9F6F2283DA7946596C9 | first-look-v5.1.json/records/144/administration_orientation | Historical; current review incomplete |
H51-A2967BAC6408EF440E0A6E3D | first-look-v5.1.json/records/144/renal_and_population_orientation | Historical; current review incomplete |
H51-867F27EECFAF82BF12F31553 | first-look-v5.1.json/records/144/key_safety_orientation/0 | Historical; current review incomplete |
H51-D3C5E76E6E4EFFA13C91CF2B | first-look-v5.1.json/records/144/key_safety_orientation/1 | Historical; current review incomplete |
H51-D224AC62DEC6DE5FD33ECDF1 | first-look-v5.1.json/records/144/coverage_path | Historical; current review incomplete |
H51-0EE481ED4252D883AC88F24F | first-look-v5.1.json/records/144/coverage_path_label | Historical; current review incomplete |
H51-4B541B7B69C799D2CA946F73 | first-look-v5.1.json/records/144/official_label_url | Historical; current review incomplete |
H51-8F63BA84FBDE32ECB0631D29 | first-look-v5.1.json/records/144/legacy_title | Historical; current review incomplete |
H51-B2E6797BFCEB1C05EB6502DB | first-look-v5.1.json/records/144/review_note | Historical; current review incomplete |
H51-EC652A9DC0D26BF3FD7FD036 | first-look-v5.1.json/records/144/search_text | Historical; current review incomplete |
H51-B8037725267EF1A57E8B6B09 | first-look-v5.1.json/records/144/official_search_url | Historical; current review incomplete |
H51-A03032387AFBCF73A9A3F211 | first-look-v5.1.json/records/144/official_access_mode | Historical; current review incomplete |
H51-48DFD1AE65CB91A2ABBBD178 | first-look-v5.1.json/records/144/official_access_url | Historical; current review incomplete |
H51-0FAF62B13AA89461C5B651F6 | first-look-v5.1.json/records/144/official_search_query | Historical; current review incomplete |
H51-AF25259793A6E0C4DDE946FB | first-look-v5.1.json/records/144/official_access_reason | Historical; current review incomplete |
H51-B77CD7DB3F2AC769E5B27A80 | first-look-v5.1.json/records/144/label_snapshot_available | Historical; current review incomplete |
H51-1A610B7C1D7643222D194A8A | first-look-v5.1.json/records/144/label_snapshot_setid | Historical; current review incomplete |
H51-BCA92F09C915AB9D3630D9B0 | preparation-assessments-v3.8.json/144/id | Historical; current review incomplete |
H51-192DC07FE3906E1C14374578 | preparation-assessments-v3.8.json/144/name | Historical; current review incomplete |
H51-6703F109D7376B6DB42F805C | preparation-assessments-v3.8.json/144/brands | Historical; current review incomplete |
H51-0D934D7E2AA5467F3EEB41A5 | preparation-assessments-v3.8.json/144/therapeutic_class | Historical; current review incomplete |
H51-B64622538EB3B563ADF00582 | preparation-assessments-v3.8.json/144/review_version | Historical; current review incomplete |
H51-02DA0C304B4E1B9DB67BFE53 | preparation-assessments-v3.8.json/144/review_date | Historical; current review incomplete |
H51-3AEFFD95A13DD9436970D8D1 | preparation-assessments-v3.8.json/144/release_status | Historical; current review incomplete |
H51-D62E299FD99A797C30672E3D | preparation-assessments-v3.8.json/144/market_status/status | Historical; current review incomplete |
H51-04DF267985B15CE68962A131 | preparation-assessments-v3.8.json/144/market_status/basis | Historical; current review incomplete |
H51-1068DF5B4348CADC6B69C01D | preparation-assessments-v3.8.json/144/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-33399054EC4543C783024B20 | preparation-assessments-v3.8.json/144/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-CEF6F90AA8A2A3C55DC14C33 | preparation-assessments-v3.8.json/144/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-53FBCDD0DEFFE4417C34D244 | preparation-assessments-v3.8.json/144/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-98A424C8D3F4B2DB2901B82C | preparation-assessments-v3.8.json/144/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-51EB610E4325194ABBC9984E | preparation-assessments-v3.8.json/144/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-02B342AF584844F26B8042B8 | preparation-assessments-v3.8.json/144/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-46E0169269B555E4D76F2D07 | preparation-assessments-v3.8.json/144/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-6D01025B76B84E31A1A2A6BE | preparation-assessments-v3.8.json/144/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-5F5727DA1498FDB0C00C2311 | preparation-assessments-v3.8.json/144/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-8E2470767BE9BDBB3BFC736A | preparation-assessments-v3.8.json/144/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-8CF13C00664D9AFDD1997D62 | preparation-assessments-v3.8.json/144/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-AD881EE0AAC4A6A06EDA34F5 | preparation-assessments-v3.8.json/144/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-BBF130FADE3305570512A0E3 | preparation-assessments-v3.8.json/144/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-156B476CE3A772B7424DD1A7 | preparation-assessments-v3.8.json/144/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-9A09CA7B23FF9260A680DC17 | preparation-assessments-v3.8.json/144/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-DE12C105DF1021A855A2D2FC | preparation-assessments-v3.8.json/144/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-D40CD1EB72A2760F3FFFA3B4 | preparation-assessments-v3.8.json/144/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-D5D7D3F73F40320CE64690D6 | preparation-assessments-v3.8.json/144/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-AD5E30E35193FC3B9BDA517B | preparation-assessments-v3.8.json/144/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-18FDE8895009589CB1E78021 | preparation-assessments-v3.8.json/144/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-E5305CA7A105772BFD686C4B | preparation-assessments-v3.8.json/144/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-50EBD0CC6AF279C862C70E53 | preparation-assessments-v3.8.json/144/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-6DCEA7FD1303D8C2B037C3A9 | preparation-assessments-v3.8.json/144/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-A093CEE43C023B27685E40AC | preparation-assessments-v3.8.json/144/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-FEED401D04F749FFF126F307 | preparation-assessments-v3.8.json/144/population_applicability/adult/applicability | Historical; current review incomplete |
H51-9E1D8EA051744A02D2C17C20 | preparation-assessments-v3.8.json/144/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-6596683324DFAE11678CD41F | preparation-assessments-v3.8.json/144/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-6C6FDB761E7E5D6C782D6F0B | preparation-assessments-v3.8.json/144/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-F2E06C99FE9E9B11993CA919 | preparation-assessments-v3.8.json/144/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-47B35A298120B9618EBD791A | preparation-assessments-v3.8.json/144/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-A8E82FB3AC12638F172829DA | preparation-assessments-v3.8.json/144/route_presence/structured_dilution | Historical; current review incomplete |
H51-5E380301450D86A1E414BFC2 | preparation-assessments-v3.8.json/144/route_presence/iv_push | Historical; current review incomplete |
H51-9715DDA077012B9A6F087D2D | preparation-assessments-v3.8.json/144/route_presence/continuous_infusion | Historical; current review incomplete |
H51-B7F1B8499812B41A9D6B8221 | preparation-assessments-v3.8.json/144/route_presence/pediatric_source | Historical; current review incomplete |
H51-294118602529701A8A1E7F9B | preparation-assessments-v3.8.json/144/route_presence/neonatal_source | Historical; current review incomplete |
H51-0BF915FF33D5C7C72B6E9082 | preparation-assessments-v3.8.json/144/legacy_reference/status | Historical; current review incomplete |
H51-882936034BBE320BBAEBBBA1 | preparation-assessments-v3.8.json/144/label_resolution/status | Historical; current review incomplete |
H51-94C078ECD8B054E78F80F558 | preparation-assessments-v3.8.json/144/label_resolution/existing_setids/0 | Historical; current review incomplete |
H51-7724139FDA90BBE662356A94 | preparation-assessments-v3.8.json/144/concentration_values_detected/0 | Historical; current review incomplete |
H51-8C7E2EF8EEFBBD4AF59AA99F | preparation-assessments-v3.8.json/144/concentration_values_detected/0/low | Historical; current review incomplete |
H51-4AC9C6B9D01D60B92ACEEB68 | preparation-assessments-v3.8.json/144/concentration_values_detected/0/high | Historical; current review incomplete |
H51-E513254F3EFB8999B17F95A8 | preparation-assessments-v3.8.json/144/concentration_values_detected/0/unit | Historical; current review incomplete |
H51-60508C0EBF44AB06EEEBEE3C | preparation-assessments-v3.8.json/144/concentration_values_detected/0/text | Historical; current review incomplete |
H51-4B05123F41A0E2A1FAED3EE1 | preparation-assessments-v3.8.json/144/source_files/0 | Historical; current review incomplete |
H51-58A0A1364EC9425C320A2CDE | preparation-assessments-v3.8.json/144/source_files/1 | Historical; current review incomplete |
H51-BB24117F01AB73A38981CCE4 | preparation-assessments-v3.8.json/144/source_files/2 | Historical; current review incomplete |
H51-B558E50D9F565EBE80806400 | preparation-assessments-v3.8.json/144/clinical_release_note | Historical; current review incomplete |